Acadian Asset Management
SNNA

Acadian Asset Management’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Acadian Asset Management’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,936
Closed – – 2414
2020
Q1 		$0 Hold
15,936
– – ﹤0.01% 2031
2019
Q4 		$1K Hold
15,936
– – ﹤0.01% 1811
2019
Q3 		$3K Hold
15,936
– – ﹤0.01% 1836
2019
Q2 		$14K Sell
15,936
-16,839
-51% -$26.4K ﹤0.01% 1624
2019
Q1 		$76K Buy
+32,775
New +$88.8K ﹤0.01% 1586

Acadian Asset Management's SNNA Position: Q2 2020 in Review

Acadian Asset Management sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2020, closing a stake of 15,936 shares.

Acadian Asset Management first reported a position in SNNA in Q1 2019 and held it in 5 quarters. The position peaked at $76K in Q1 2019. 0 funds tracked by Wall St. Rank hold SNNA as of Q2 2020.

  • Acadian Asset Management reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Acadian Asset Management sold 15,936 Sienna Biopharmaceuticals, Inc. shares in Q2 2020.
  • Acadian Asset Management first reported a position in Sienna Biopharmaceuticals, Inc. in Q1 2019 and held it in 5 quarters.
  • Acadian Asset Management's Sienna Biopharmaceuticals, Inc. position peaked at $76K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2020.

Based on Acadian Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.